Company intelligence / Profile preview

VIVIS

Katy, Texas, United States

Ownership: Private
Development stage: Other

Overview

VIVIS was a U.S.-based hemp wellness company that marketed CBD-based health and nutritional products, including tinctures, topicals, softgels, oils, and a menthol-infused sports cream. The business appears to have focused on consumer cannabinoid products positioned for pain, anxiety, neuroinflammation, and other wellness-related uses rather than a regulated biopharma drug pipeline. VIVIS was founded in 2018 in Texas and was acquired by Neutra Corp. on September 10, 2019. After the acquisition, the VIVIS brand was used within Neutra's CBD retail strategy. It does not appear to be an active standalone biotech or pharmaceutical company today.

Therapeutic areas: PsychiatryNeurologyGastroenterology
Modalities: Small molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on VIVIS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIVIS.

Explore the full profile